HIV Vaccine Trials Network
E63970
The HIV Vaccine Trials Network is a global clinical trials organization dedicated to developing and testing preventive HIV vaccines through large-scale, collaborative research.
All labels observed (2)
| Label | Occurrences |
|---|---|
| HIV Vaccine Trials Network canonical | 1 |
| HVTN | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T513554 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: HIV Vaccine Trials Network Context triple: [Duke Human Vaccine Institute, collaboratesWith, HIV Vaccine Trials Network]
-
A.
Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing organization that mobilizes and invests resources to accelerate the end of these three major infectious diseases worldwide.
-
B.
UNAIDS
UNAIDS is the Joint United Nations Programme on HIV/AIDS, leading and coordinating global efforts to prevent HIV infection, expand treatment, and support people living with HIV.
-
C.
National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases is a U.S. federal biomedical research agency that leads research and policy on infectious, immunologic, and allergic diseases.
-
D.
Office of National AIDS Policy
The Office of National AIDS Policy is a White House office responsible for coordinating the U.S. federal government’s efforts to prevent and treat HIV/AIDS and develop related national strategies.
-
E.
Center for Biostatistics in AIDS Research
The Center for Biostatistics in AIDS Research is a Harvard-based research center that develops and applies advanced statistical methods to improve the design, analysis, and interpretation of HIV/AIDS clinical and epidemiological studies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: HIV Vaccine Trials Network Target entity description: The HIV Vaccine Trials Network is a global clinical trials organization dedicated to developing and testing preventive HIV vaccines through large-scale, collaborative research.
-
A.
Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing organization that mobilizes and invests resources to accelerate the end of these three major infectious diseases worldwide.
-
B.
UNAIDS
UNAIDS is the Joint United Nations Programme on HIV/AIDS, leading and coordinating global efforts to prevent HIV infection, expand treatment, and support people living with HIV.
-
C.
National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases is a U.S. federal biomedical research agency that leads research and policy on infectious, immunologic, and allergic diseases.
-
D.
Office of National AIDS Policy
The Office of National AIDS Policy is a White House office responsible for coordinating the U.S. federal government’s efforts to prevent and treat HIV/AIDS and develop related national strategies.
-
E.
Center for Biostatistics in AIDS Research
The Center for Biostatistics in AIDS Research is a Harvard-based research center that develops and applies advanced statistical methods to improve the design, analysis, and interpretation of HIV/AIDS clinical and epidemiological studies.
- F. None of above. chosen
Statements (45)
| Predicate | Object |
|---|---|
| instanceOf |
HIV vaccine research consortium
ⓘ
clinical trials network ⓘ research organization ⓘ |
| abbreviation |
HIV Vaccine Trials Network
self-linksurface differs
ⓘ
surface form:
HVTN
|
| aimsTo |
accelerate HIV vaccine development
ⓘ
inform global HIV prevention strategies ⓘ |
| collaboratesWith |
National Institute of Allergy and Infectious Diseases
ⓘ
National Institutes of Health ⓘ community organizations ⓘ research hospitals ⓘ universities ⓘ |
| coordinates |
international trial sites
ⓘ
multinational research teams ⓘ |
| emphasis |
community engagement
ⓘ
data quality ⓘ ethical conduct of research ⓘ participant safety ⓘ |
| field |
HIV vaccine research
ⓘ
clinical trials ⓘ immunology ⓘ infectious diseases ⓘ |
| focus |
HIV prevention
ⓘ
preventive HIV vaccines ⓘ vaccine safety and efficacy ⓘ |
| goal |
develop effective preventive HIV vaccines
ⓘ
evaluate HIV vaccine candidates in humans ⓘ understand immune responses to HIV vaccines ⓘ |
| hasParticipantType |
clinical trial volunteers
ⓘ
clinicians ⓘ community representatives ⓘ scientists ⓘ |
| method |
multicenter clinical trials
ⓘ
randomized controlled trials ⓘ |
| researchArea |
phase 1 HIV vaccine trials
ⓘ
phase 2 HIV vaccine trials ⓘ phase 3 HIV vaccine trials ⓘ |
| scope | global ⓘ |
| studies |
HIV acquisition rates in trial participants
ⓘ
HIV vaccine immunogenicity ⓘ HIV vaccine safety ⓘ |
| subjectOf |
HIV vaccine trial reports
ⓘ
peer-reviewed scientific publications ⓘ |
| typeOfOrganization | nonprofit research network ⓘ |
| uses |
ICH E6 Good Clinical Practice
ⓘ
surface form:
Good Clinical Practice guidelines
standardized clinical trial protocols ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: HIV Vaccine Trials Network Description of subject: The HIV Vaccine Trials Network is a global clinical trials organization dedicated to developing and testing preventive HIV vaccines through large-scale, collaborative research.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.